Study on Dopamine D2 Receptors and Cardiomyocyte Apoptosis Retracted by Journal of Biomedical Science

A recent study examining the role of dopamine D2 receptors in ischemia/reperfusion-induced apoptosis of cultured neonatal rat cardiomyocytes has been officially retracted. The Journal of Biomedical Science issued the retraction notice, which has drawn significant attention from researchers and the broader public. The study initially explored how these receptors might influence cardiac cell survival under conditions of stress, such as restricted blood flow followed by restoration (ischemia/reperfusion).

The retraction highlights concerns regarding the validity of the findings presented in the research. While details surrounding the reasons for withdrawal remain limited, such actions typically stem from issues related to data accuracy, methodology, or ethical considerations. The original publication had aimed to shed light on potential mechanisms that could inform future therapeutic strategies for heart-related conditions. However, with its removal from scientific literature, questions now arise about the reliability of its conclusions and their implications for ongoing research in this field.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

Related posts:

Drug Patent Watch Blog Releases Guide Outlining Key Steps for Effective Drug Patent Searching Trastuzumab Deruxtecan Shows Efficacy in HER2-Positive Breast Cancer After Pyrotinib Failure Study Explores Cardiovascular Effects of Testosterone Therapy in Transgender Individuals New Huiyingosmylus Species with Unique Foreleg Structure Identified in Middle Jurassic Fossils of China

Author

GOAI